United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Jun 18, 2026 · Filed Jun 22, 2026

On Jun 18, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$540.15 for US$5.4M under a trading plan, leaving 18,876 shares. Filed Jun 22, 2026 (Form 4).

Sold
10,000 shares
Price
US$540.15 average (US$533.59 to US$548.90)
Value
US$5.4M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 18, 2026Common StockOption exercise10,000US$146.0328,876Direct
Jun 18, 2026Common StockSale400US$533.5928,476Direct
Jun 18, 2026Common StockSale160US$534.4828,316Direct
Jun 18, 2026Common StockSale210US$536.2728,106Direct
Jun 18, 2026Common StockSale600US$537.2427,506Direct
Jun 18, 2026Common StockSale1,440US$538.3126,066Direct
Jun 18, 2026Common StockSale2,035US$539.4224,031Direct
Jun 18, 2026Common StockSale2,978US$540.2221,053Direct
Jun 18, 2026Common StockSale865US$541.0620,188Direct
Jun 18, 2026Common StockSale192US$541.8819,996Direct
Jun 18, 2026Common StockSale40US$543.5319,956Direct
Jun 18, 2026Common StockSale40US$545.1919,916Direct
Jun 18, 2026Common StockSale265US$547.3719,651Direct
Jun 18, 2026Common StockSale115US$547.8119,536Direct
Jun 18, 2026Common StockSale660US$548.9018,876Direct

Source

View original at SEC

Related